End-of-day quote
Taiwan S.E.
18:00:00 2024-04-02 EDT
|
5-day change
|
1st Jan Change
|
3.57
TWD
|
-9.85%
|
|
-.--%
|
-15.40%
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Capitalization
1 |
903.3
|
652.7
|
600.2
|
442.9
|
496.8
|
409.4
|
Enterprise Value (EV)
1 |
711.1
|
454.6
|
508.3
|
330
|
196
|
133.2
|
P/E ratio
|
-3.33
x
|
-1.68
x
|
-2.17
x
|
-0.98
x
|
-4.67
x
|
5.88
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
1.15
x
|
0.55
x
|
0.87
x
|
0.94
x
|
2.36
x
|
18
x
|
EV / Revenue
|
0.91
x
|
0.38
x
|
0.74
x
|
0.7
x
|
0.93
x
|
5.87
x
|
EV / EBITDA
|
-3.9
x
|
-1.94
x
|
-1.88
x
|
-1.56
x
|
-1.7
x
|
-1.75
x
|
EV / FCF
|
-1.82
x
|
-1.92
x
|
18.5
x
|
-7.85
x
|
1.34
x
|
-0.44
x
|
FCF Yield
|
-55%
|
-52%
|
5.4%
|
-12.7%
|
74.7%
|
-229%
|
Price to Book
|
0.65
x
|
0.66
x
|
0.67
x
|
0.91
x
|
1.31
x
|
0.9
x
|
Nbr of stocks (in thousands)
|
145,687
|
145,687
|
145,687
|
145,687
|
145,687
|
145,687
|
Reference price
2 |
6.200
|
4.480
|
4.120
|
3.040
|
3.410
|
2.810
|
Announcement Date
|
3/29/18
|
4/1/19
|
3/31/20
|
3/31/21
|
3/31/22
|
3/31/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net sales
1 |
785.4
|
1,187
|
690.3
|
469.7
|
210.3
|
22.68
|
EBITDA
1 |
-182.5
|
-234.9
|
-270.1
|
-211.6
|
-115.4
|
-76.31
|
EBIT
1 |
-274.8
|
-300
|
-322
|
-255
|
-128.4
|
-88.54
|
Operating Margin
|
-34.99%
|
-25.28%
|
-46.64%
|
-54.28%
|
-61.07%
|
-390.37%
|
Earnings before Tax (EBT)
1 |
-274.5
|
-345.8
|
-290.3
|
-454.9
|
-110
|
68.22
|
Net income
1 |
-270.8
|
-388.5
|
-276.3
|
-449.6
|
-105.9
|
69.58
|
Net margin
|
-34.48%
|
-32.73%
|
-40.03%
|
-95.71%
|
-50.35%
|
306.75%
|
EPS
2 |
-1.860
|
-2.670
|
-1.897
|
-3.090
|
-0.7300
|
0.4776
|
Free Cash Flow
1 |
-391
|
-236.2
|
27.45
|
-42.05
|
146.5
|
-304.8
|
FCF margin
|
-49.78%
|
-19.9%
|
3.98%
|
-8.95%
|
69.65%
|
-1,343.8%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/29/18
|
4/1/19
|
3/31/20
|
3/31/21
|
3/31/22
|
3/31/23
|
Fiscal Period: December |
2017
|
2018
|
2019
|
2020
|
2021
|
2022
|
---|
Net Debt
1 |
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
1 |
192
|
198
|
91.9
|
113
|
301
|
276
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-391
|
-236
|
27.5
|
-42.1
|
146
|
-305
|
ROE (net income / shareholders' equity)
|
-17.7%
|
-27.9%
|
-29.7%
|
-63.1%
|
-23.8%
|
15.4%
|
ROA (Net income/ Total Assets)
|
-9.05%
|
-9.98%
|
-12.4%
|
-14.4%
|
-10.8%
|
-9.34%
|
Assets
1 |
2,991
|
3,893
|
2,227
|
3,130
|
984.4
|
-744.6
|
Book Value Per Share
2 |
9.600
|
6.820
|
6.130
|
3.330
|
2.600
|
3.120
|
Cash Flow per Share
2 |
1.740
|
0.7600
|
1.250
|
1.430
|
2.480
|
1.940
|
Capex
1 |
52.3
|
200
|
157
|
5.23
|
8.08
|
47.9
|
Capex / Sales
|
6.66%
|
16.84%
|
22.81%
|
1.11%
|
3.84%
|
211.37%
|
Announcement Date
|
3/29/18
|
4/1/19
|
3/31/20
|
3/31/21
|
3/31/22
|
3/31/23
|
|
1st Jan change
|
Capi.
|
---|
| -15.40% | 16.15M | | -7.37% | 1.34B | | -11.57% | 1.32B | | -16.43% | 1.1B | | -20.64% | 818M | | -2.68% | 450M | | +1.70% | 436M | | -51.32% | 344M | | -26.58% | 327M | | -5.60% | 210M |
Medical Equipment Wholesale
|